A robust methodology to study urine microRNA as tumor marker: MicroRNA-126 and microRNA-182 are related to urinary bladder cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 28, Issue 6, 2010, Pages 655-661

  Hanke, Merle ^a,b   Hoefig, Kai ^b   Merz, Hartmut ^b   Feller, Alfred C ^b   Kausch, Ingo ^b   Jocham, Dieter ^b   Warnecke, Jens M ^a,b   Sczakiel, Georg ^a,b  

^a Kompetenzzentrum fuer Drug Design und Target Monitoring   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Bladder cancer; Cell free RNA; MiRNA; Non invasive diagnosis; Tumor marker; Urine

Indexed keywords

MICRORNA; MICRORNA 126; MICRORNA 182; TUMOR MARKER; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLADDER CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; URINARY TRACT INFECTION; URINE LEVEL;

AGED; FEMALE; HUMANS; MALE; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA STABILITY; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINALYSIS; URINARY BLADDER NEOPLASMS;

EID: 78149408296     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.01.027     Document Type: Article

References (29)

1. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nature Rev Cancer 2006, 6:857-866.
2. Lu J., Getz G., Miska E.A., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
3. Groskopf J., Aubin S.M., Deras I.L., et al. APTIMA PCA3 molecular urine test: Development of a method to aid in the diagnosis of prostate cancer. Clin Chem 2006, 52:1089-1095.
4. Bai V.U., Kaseb A., Tejwani S., et al. Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine. Proc Natl Acad Sci U S A 2007, 104:2343-2348.
5. Hanke M., Kausch I., Dahmen G., et al. Detailed technical analysis of urine RNA-based tumor diagnostics reveals ETS2/urokinase plasminogen activator to be a novel marker for bladder cancer. Clin Chem 2007, 53:2070-2077.
6. Volinia S., Calin G.A., Liu C.G., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103:2257-2261.
7. Krützfeldt J., Rajewsky N., Braich R., et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
8. Ito H., Kyo S., Kanaya T., et al. Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin Cancer Res 1998, 4:1603-1608.
9. De Kok J.B., Schalken J.A., Aalders T.W., et al. Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas. Int J Cancer 2000, 87:217-220.
10. de Kok J.B., Ruers T.J., van Muijen G.N., et al. Real-time quantification of human telomerase reverse transcriptase mRNA in tumors and healthy tissues. Clin Chem 2000, 46:313-318.
11. Isurugi K., Suzuki Y., Tanji S., et al. Detection of the presence of catalytic subunit mRNA associated with telomerase gene in exfoliated urothelial cells from patients with bladder cancer. J Urol 2002, 168:1574-1577.
12. de Kok J.B., van Balken M.R., Roelofs R.W., et al. Quantification of hTERT mRNA and telomerase activity in bladder washings of patients with recurrent urothelial cell carcinomas. Clin Chem 2000, 46:2003-2007.
13. Bialkowska-Hobrzanska H., Bowles L., Bukala B., et al. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma. Mol Diagn 2000, 5:267-277.
14. Bowles L., Bialkowska-Hobrzanska H., Bukala B., Nott L., et al. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer. Can J Urol 2004, 11:2438-2444.
15. Ito H., Kyo S., Kanaya T., et al. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer. Clin Cancer Res 1998, 4:2807-2810.
16. Weikert S., Krause H., Wolff I., et al. Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer. Int J Cancer 2005, 117:274-280.
17. de Kok J.B., van Balken M.R., Ruers T.J., et al. Detection of telomerase activity in urine as a tool for noninvasive detection of recurrent bladder tumors is poor and cannot be improved by timing of sampling. Clin Chem 2000, 46:2014-2015.
18. Neely L.A., Rieger-Christ K.M., Neto B.S., et al. A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urol Oncol 2008 Sep 15, [Epub ahead of print].
19. Budman L.I., Kassouf W., Steinberg J.R. Biomarkers for detection and surveillance of bladder cancer. Can Urol Assoc J 2008, 2:212-221.
20. Gottardo F., Liu C.G., Ferracin M., et al. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 2007, 25:387-392.
21. Garzon R., Pichiorri F., Palumbo T., et al. MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA 2006, 103:5078-5083.
22. Kuehbacher A., Urbich C., Zeiher A.M., et al. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 2007, 101:59-68.
23. Harris T.A., Yamakuchi M., Ferlito M., et al. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 2008, 105:1516-1521.
24. Tavazoie S.F., Alarcón C., Oskarsson T., et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451:147-152.
25. Guo C., Sah J.F., Beard L., et al. The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 2008, 47:939-946.
26. Crawford M., Brawner E., Batte K., et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun 2008, 373:607-612.
27. Zhang J., Du Y.Y., Lin Y.F., et al. The cell growth suppressor, mir-126, targets IRS-1. Biochem Biophys Res Commun 2008, 377:136-140.
28. Xu S., Witmer P.D., Lumayag S., et al. MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster. J Biol Chem 2007, 282:25053-25066.
29. Chang T.C., Wentzel E.A., Kent O.A., et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007, 26:745-752.